IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo
Tania Pilli(University of Siena), Furio Pacini, Lutz Schomburg(Charité - Universitätsmedizin Berlin), E Kuhn(Charité - Universitätsmedizin Berlin), E Heid(Charité - Universitätsmedizin Berlin), Carla Fioravanti(University of Siena), Gabriele D'Hauw(University of Siena), Fausta Sestini(University of Siena), Sandro Cardinale(University of Siena), Gabriele Cevenini(University of Siena), Silvia Cantara(University of Siena), Valeria Cenci(University of Siena)
Cited by 34
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316
miRNA Targets: From Prediction Tools to Experimental Validation
|Methods and Protocols|2020|240
A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal
|The Journal of Clinical Endocrinology & Metabolism|2006|198